VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
92,076
AK1,880
AL6,345
AR4,151
AS46
AZ14,991
CA66,887
CO12,550
CT8,943
DC1,795
DE2,009
FL42,724
FM4
GA17,031
GU124
HI2,580
IA4,919
ID2,892
IL22,128
IN24,197
KS5,047
KY9,111
LA5,500
MA15,718
MD13,434
ME3,351
MH8
MI20,971
MN13,585
MO10,747
MP30
MS3,198
MT2,477
NC18,051
ND1,501
NE3,109
NH3,218
NJ20,216
NM4,218
NV4,728
NY37,667
OH20,793
OK6,692
OR9,244
PA25,607
PR2,588
QM2
RI2,163
SC7,261
SD1,282
TN10,445
TX39,890
UT4,618
VA15,980
VI67
VT1,830
WA16,071
WI12,042
WV2,571
WY926
XB5
XL1
XV2

ID: 1010603
Sex: F
Age:
State: MN

Vax Date: 01/19/2021
Onset Date: 01/20/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever; Chills; Headache; Severe neck Pain; Muscle ache; Joint pain; Malaise; Fatigue; Nausea; Dizziness; Insomnia; This is a spontaneous report from a contactable healthcare professional reporting for herself. A 51-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number EL3302/expiration date: not provided), via intramscular route of administration, on 19Jan2021 04:15 PM (at the age of 51 years old) as a single dose in the right arm for COVID-19 IMMUNIZATION. Relevant medical history included Hashimoto's Thyroiditis and hypothyroidism. The patient had known allergies to levofloxacin, amoxicillin, levonorgestrel and ethinyl estradiol and pineapple. The patient previously received the first dose of BNT162B2 (lot number EJ1685) via intramuscular route of administration on 29Dec2020 at 04:15 AM (at the age of 51 years old), as a single dose in the left arm for COVID-19 IMMUNIZATION. On 05Jan2021, at 01:00 PM, the patient experienced headache, bodyaches, confusion, nausea, no appetite, fatigue, malaise, loose stools, joint pain, muscle pain, kidney pain, and watery eyes. The patient did not receive treatment for these events and has recovered from the events. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included thyroid (ARMOUR THYROID) and naltrexone. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines (besides the first dose of BNT162B2) within 4 weeks prior to the COVID vaccine. On 20Jan2021 at 04:00 AM the patient experienced fever, chills, headache, severe neck pain, muscle ache, joint pain, malaise, fatigue, nausea, dizziness, and insomnia. The patient did not receive any treatment for these events. The outcome of the events fever, chills, headache, severe neck pain, muscle ache, joint pain, malaise, fatigue, nausea, dizziness, and insomnia was recovering. Since the vaccination, the patient had not been tested for COVID-19.

Other Meds: ARMOUR THYROID; NALTREXONE

Current Illness:

ID: 1010604
Sex: F
Age:
State: MI

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: cellulitis in arm; Dizzy head; sore; a few lymph nodes reacted; This is a spontaneous report from a contactable consumer. A 39-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unknown date in Jan2021 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. It was unknown if patient was pregnant. The patient received the first dose of BNT162B2 (lot number: EL0140) on 28Dec2020 for covid-19 immunization. On an unknown date in Jan2021, the patient experienced Dizzy head and sore. Then injection site swelling and was hot to the touch and a few lymph nodes reacted. Two days of 102+ fever, diagnosis of cellulitis in arm. Antibiotics received for cellulitis. Adverse event result in Doctor or other healthcare professional office/clinic visit. The outcome of the events was recovering. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1010605
Sex: F
Age:
State: MN

Vax Date: 12/29/2020
Onset Date: 01/05/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache; Bodyaches; Confusion; Nausea; No Appetite; Fatigue; Malaise; Loose stools; Joint pain; Muscle Pain; Kidney Pain; Watery eyes; This is a spontaneous report from a contactable other hcp (patient). A 51-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EJ1685) intramuscularly in left arm on 29Dec2020 16:15 at single dose for COVID-19 immunization. Medical history included Hashimoto's Thyroiditis, Hypothyroidism, known allergies to pineapple. Concomitant medication included thyroid (ARMOUR THYROID), naltrexone. The patient previously took levofloxacin and experienced allergies, amoxicillin and experienced allergies, levonorgestrel and ethinyl estradiol (reported as LEVONORGESTREL-ETHINYL) and experienced allergies. The patient experienced headache, bodyaches, confusion, nausea, no appetite, fatigue, malaise, loose stools, joint pain, muscle pain, kidney pain, watery eyes, all on 05Jan2021 13:00. No treatment received. No other vaccine in four weeks. No covid prior vaccination. The patient underwent lab tests and procedures which included Nasal Swab with result of negative on 10Jan2021. The outcome of the events was recovered in Jan2021.

Other Meds: ARMOUR THYROID; NALTREXONE

Current Illness:

ID: 1010606
Sex: F
Age:
State: CA

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache; flush; diaphoretic; stiff neck; This is a spontaneous report from a contactable pharmacist (patient). A 51-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; brand: Pfizer; lot number: cl3249) intramuscularly at left arm on 22Jan2021 at 11:45 AM at a single dose for COVID-19 immunization. Medical history included hypothyroid, asthma, seasonal allergies and known allergies: bee stings. The patient was not pregnant. No other vaccine in four weeks. Other medications in two weeks included levothyroxine. The patient experienced adverse events included headache, flush, diaphoretic, stiff neck; with start date on 22Jan2021 at 12:00 PM. Treatment ibuprofen received for events. The outcome of events was resolving. No covid prior vaccination and no covid tested post vaccination.

Other Meds: LEVOTHYROXINE

Current Illness:

ID: 1010607
Sex: M
Age:
State: MI

Vax Date: 01/20/2021
Onset Date: 01/21/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever; This is a spontaneous report from a non-contactable consumer (patient himself). A 38-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EC0142), via an unspecified route of administration, on 20Jan2021, at single dose, for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EC1284) on 30Dec2020 for covid-19 immunization at 38-years-old. The patient experienced having a fever on 21Jan2021, the day following dose 2 vaccination. No treatment was received for the event. The patient recovered from the event on Jan2021. The patient did not have COVID prior to vaccination and have not been COVID tested post vaccination. It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1010608
Sex: M
Age:
State:

Vax Date:
Onset Date: 01/12/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: 10 days ago I developed the virus; 10 days ago I developed the virus; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were unknown), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient reported that he had the first Pfizer COVID vaccine dose and he was scheduled to get the 2nd dose on 25Jan2021. He reported that 10 days ago (12Jan2021) he developed the virus. The patient asked if he should wait longer to get his 2nd dose. The outcome of the event was unknown. Information on the Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 1010609
Sex: M
Age:
State: NC

Vax Date: 01/17/2021
Onset Date: 01/17/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: diminished use of my left thumb in picking pills off counter and tying my shoelaces; tingly feeling in my left palm and thumb; discomfort/ache in my left hand; aching in my left hand, wave like impact/ pain (not ache) in my left mid finger; This is a spontaneous report from a contactable consumer (patient). A 70-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3249 and expiration date not provided), via an unspecified route of administration in the left arm on 17Jan2021 16:00 at a single dose for COVID-19 immunization. Medical history included High cholesterol and bypass surgery. Concomitant medications included metoprolol, famotidine, ezetimibe, and atorvastatin. The patient had no known allergies. The patient did not receive any other vaccine in 4 weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had his first COVID vaccine shot on 17Jan2021 16:00. On 17Jan2021 22:00, the patient had an onset of aching in his left hand, wave like impact. The ache became more intense, and then receded, then more intense, then receded, etc. That night, 18Jan2021, he woke up at 03:30 with a pain (not ache) in my left mid finger. Then 30 min later, it receded and he fell back asleep. On Monday, 18Jan2021, he woke up with discomfort/ache in his left hand. It disappeared by mid afternoon of 18Jan2021. On Tuesday, 19Jan2021 02:00, he woke up with pain in his mid finger left hand which again receded and he went back to sleep. On Thursday, 21Jan2021, he noted a diminished use of his left thumb in picking pills off counter and tying his shoelaces. He can replicate the tingly feeling in his left palm and thumb by inverting his hands and stretching them away from him. The events resulted in Doctor or other healthcare professional office/clinic visit. It was unknown if treatment was given in response to the events. The outcome of the events pain in extremity was recovered on 19Jan2021 and limb discomfort was recovered on 18Jan2021 while the outcome of the rest of the events was not recovered. The patient has not been tested for COVID post vaccination.

Other Meds: METOPROLOL; FAMOTIDINE; EZETIMIBE; ATORVASTATIN

Current Illness:

ID: 1010610
Sex: M
Age:
State: DC

Vax Date: 01/21/2021
Onset Date: 01/01/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: profuse vomiting, no nausea/had a huge episode of vomiting; felt really tired/felt tired; sleeping; This is a spontaneous report from a contactable nurse. A 76-year-old male patient received 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot # EL3302, expiration date: 31May2021), via an unspecified route of administration on 21Jan2021 at 11:00 at single dose on left arm for gain immunity against Covid-19. Medical history included stroke from 2017. There were no concomitant medications. Caller was reporting on her husband. He received the first dose of the Covid-19 vaccine yesterday (21Jan2021). He felt tired today (22Jan2021). 24 hours after he received the vaccine, he had a huge episode of vomiting. He was not nauseated and didn't even feel sick. He ate this morning as usual. All of a sudden he vomited. He still did not feel nauseated. He was tired on 22Jan2021 and was sleeping in Jan2021. Reporter had not measured his temperature but said he did not have a fever. He hadn't vomited in years. Outcome of the events was unknown. This case was reported as non-serious.

Other Meds:

Current Illness:

ID: 1010611
Sex: F
Age:
State: LA

Vax Date: 01/14/2021
Onset Date: 01/15/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: welts/ she has had welts before in the past/welts on right and left arm, Left shoulder, Right buttocks fold, and both lowers legs; welts/she has had welts before in the past/welts on right and left arm, Left shoulder, Right buttocks fold, and both lowers legs; Itching; This is a spontaneous report from a contactable consumer. a 78-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1283, expiration date: 30Apr2021, NDC number: 5926710001) on 14Jan2021 at right arm at single dose for covid-19 immunization. Medical history included Welts. Concomitant medication was not reported. Caller is a Pharmacy Tech and a patient had the first dose of the Covid 19 vaccine and had itching (15Jan2021) and whelps (17Jan2021). She would like to know if these are normal side effects and if the patient can get the 2nd dose. Pharmacy Technician is calling about the Covid Vaccine. It was administered to a patient and the patient experienced an AE. Pharmacy Technician clarifies that she is calling on behalf of the patient. She started itching a little on Friday 15Jan2021, then Sunday she started getting welts that were the size of pencil erasers to a dime. She would take Benadryl and when she took it, she was fine for 24 hours. Then welts every day, in different areas, she had the welts on right and left arm, Left shoulder, Right buttocks fold, and both lowers legs. The added that she has had welts before in the past but she was not sure what caused them in the past. Reporter does not know if the itching and welts are still ongoing or when it stopped. The Patient did state that Itching went away with Benadryl however reporter does not know when or if that is still the case. Not sure when it stopped. Patient didn't provide end dates or if the adverse events ended. The Patient did not list any allergies. When queried if the patient had any positive covid or antibody test prior to the vaccine, caller states that all of the patients that they vaccinated, they ask them if they had any positive test within 90 days, all stated no, if they state, they do not give the vaccine and make then wait. Caller asks if there is any information about if these side effects are normal, as well as if the patient is still able to receive the second dose. the last outcome of the events was unknown. It was reported as non-serious.

Other Meds:

Current Illness:

ID: 1010612
Sex: F
Age:
State: TN

Vax Date: 01/21/2021
Onset Date: 01/01/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: increased heart rate; palpitations; numbness around the mouth; arm is hot and sore; arm is hot and sore; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age (reported as 77 with unknown units) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 21Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported that after her second dose of the Pfizer COVID 19 vaccine on 21Jan2021, she had increased heart rate, palpitations and numbness around the mouth, arm was hot and sore (Jan2021). The patient stated she had water with her, and the symptoms went away. The outcome of the events was recovered in Jan2021. Information on lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1010613
Sex: F
Age:
State: FL

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: mild numbness on her throat; This is a spontaneous report from a contactable consumer (patient). This 80-year-old female patient received her 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL3426) at single dose on 08Jan2021 via an unknown route at left arm for Covid-19 immunization, which was recommended for her age. Medical history included ongoing cervical spinal stenosis for 5 or more years (no investigation assessment, no relevant tests), high cholesterol, high blood pressure, heart beat. Concomitant drugs included ongoing amlodipine besilate 5 mg twice daily for high blood pressure, ongoing atorvastatin 10mg daily for high cholesterol, ongoing hydrochlorothiazide 12.5 mg daily for high blood pressure, ongoing losartan 10 mg daily for blood pressure, ongoing metoprolol tartrate 25 mg twice daily for heart beat. Patient had been taking atorvastatin, hydrochlorothiazide, amlodipine besilate for a long time. Patient had been taking losartan for 10-11 years. Patient had been taking metoprolol tartrate for 4-5 years. No history of all previous immunization with the Pfizer vaccine considered as suspect, no additional vaccines administered on same date of the Pfizer Suspect. No prior vaccinations within 4 weeks. She experienced having mild numbness on her throat on 08Jan2021 that lasted for an hour and a half. The event clinical course was as follows: After waiting 15 minutes she was ok and was cleared to go. On the way to her car she felt numbness in her throat. It was mild and lasted for an hour and a half and then it cleared on its own. No Emergency Room or Physician Office visit required due to the event. She was scheduled to get the 2nd dose of the COVID-19 vaccine on 29Jan2021. She wanted recommendations on whether she should take the second dose of the vaccine. She was concerned if that would be a problem with getting the second shot. She was asking if this could happen again. Outcome of the event was resolved on 08Jan2021.

Other Meds: AMLODIPINE BESILATE; ATORVASTATIN; HYDROCHLOROTHIAZIDE; LOSARTAN; METOPROLOL TARTRATE

Current Illness: Cervical spinal stenosis

ID: 1010614
Sex: F
Age:
State:

Vax Date: 01/14/2021
Onset Date: 01/15/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: had diarrhea badly, 6-7 bowel movements a day; injection site stiffness; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were not reported), via an unspecified route of administration on 14Jan2021 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported, "I received my first dose on Thursday 14Jan2021 and then the next morning I had diarrhea badly, 6-7 bowel movements a day, and injection site stiffness. Should I get the second dose?" Outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1010615
Sex: F
Age:
State:

Vax Date: 01/09/2021
Onset Date: 01/01/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Since receiving the vaccine it "went down on its own and its staying down".; This is a spontaneous report from a contactable consumer (patient). A 75-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 09Jan2021 at single dose for covid-19 immunization. Medical history included diabetes from an unknown date. The patient's concomitant medications were not reported. The patient has diabetes and typically her "sugar runs high" but since receiving the vaccine, within a few days of having the shot, sugar went down all on its own, and its staying down. The patient wanted to document her experience as a positive effect to the vaccine, as she has not made any other lifestyle changes. The outcome of the event was unknown. No follow up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1010616
Sex: F
Age:
State: NY

Vax Date:
Onset Date:
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: having stomach issues; This is a spontaneous report from a contactable consumer (patient). This 79-year-old female patient received the 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. Medical history and concomitant medications were unknown. The patient explained that the hospital gave her a document presenting an interval varying between "17-24 or 28 days" for the second dose of the COVID-19 vaccine. She stated that her appointment for the second dose was 17 days after the first dose, and asked if this timing was "legitimate". The patient had first dose of covax, inquiring on the change of having second dose after 17days instead of 21 days. The patient had to hang up, stated she was having stomach issues, was not able to transfer. Outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1010617
Sex: M
Age:
State: FL

Vax Date: 01/06/2021
Onset Date: 01/07/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fast heartbeat; This is a spontaneous report from a contactable consumer reporting for self. This 82-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 06Jan2021 at left upper arm at single dose for COVID-19 immunisation. Medical history included blood pressure abnormal and blood cholesterol abnormal. Concomitant medications included lisopnphill (as reported, spelling as provided by caller- as close as he can get) started it 3 years ago (in 2018) for blood pressure; pravastatin started about 3 years ago (in 2018) for cholesterol. On 07Jan2021, patient experienced a fast heartbeat for about a minute when was going to lay down to go to sleep. He had not had the other symptoms like dizziness or chills, and did not experience a rash, dizziness, or swelling all over face, that had not happened. He saw his primary guy 3 days after and all his counts were good, his blood pressure and everything, etc. so they didn't suspect anything at this time. He will go ahead with the second shot. He had an exam with his private doctor on 12Jan2021, and everything was fine. The outcome of event was recovered on 07Jan2021. Information on the lot/batch number has been requested.

Other Meds: PRAVASTATIN

Current Illness:

ID: 1010618
Sex: M
Age:
State: FL

Vax Date: 01/20/2021
Onset Date: 01/22/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache; Horizontal red line of swelling at the injection site; Horizontal red line of swelling at the injection site; Nausea; Circular rash on the shoulder; This is a spontaneous report from a contactable consumer (patient). A 77-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL1283; Expiration date was not reported) on 20Jan2021 (12:30) at a single dose on the right arm, with route of administration unspecified, for COVID-19 immunization. Medical history included high blood pressure (HBP); atrial fibrillation (atrial fib.); sleep apnea; heart disease; contrast dye allergy; and mold allergy. Concomitant medications included losartan, carvedilol (COREG) and piroxicam (MAXIDENE). On 22Jan2021 (08:00), the patient had headache; horizonal red line of swelling at the injection site; nausea; and circular rash on the shoulder. The patient did not receive any treatment for all the reported events. The outcome of the events, 'headache', 'horizonal red line of swelling at the injection site', 'nausea' and 'circular rash on the shoulder', was not recovered. The patient was not diagnosed with COVID-19 prior to the vaccination, and was not tested post-vaccination.

Other Meds: LOSARTAN; COREG; MAXIDENE

Current Illness:

ID: 1010619
Sex: F
Age:
State: AZ

Vax Date: 01/06/2021
Onset Date: 01/19/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tested positive for covid 19/it was a swab in her nostrils; tested positive for covid 19/it was a swab in her nostrils; This is a spontaneous report from a contactable consumer reporting for self. This 34-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899) on 06Jan2021 around 14:30-14:45 at left arm at single dose for COVID-19 immunisation. Medical history and concomitant medications were none. No prior vaccinations within 4 weeks and no AEs follow prior vaccinations. Family medical history included diabetes. The patient received 1st dose of vaccine on 06Jan2021, tested positive for COVID 19 on 19Jan2021. Unable to provide which COVID test she received. Stated she was tested at (Pharmacy) and it was a swab in her nostrils. She was scheduled for 2nd dose on 27Jan2021 at 15:45 and asking if she can/should get the 2nd dose. The outcome of event was unknown.

Other Meds:

Current Illness:

ID: 1010620
Sex: F
Age:
State: NC

Vax Date: 01/20/2021
Onset Date: 01/21/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Caller reports worsening hip and leg pain/her hips and legs feel real achy, she has achiness in her hips and legs; Caller reports worsening hip and leg pain/her hips and legs feel real achy, she has achiness in her hips and legs; her arm was sore yesterday but better today/her arm was sore; This is a spontaneous report from a contactable consumer (patient). A 73-year-old female patient received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/lot number: EL3247), via an unspecified route of administration in left arm on 20Jan2021 at single dose for COVID-19 immunization. Medical history included ongoing 'sometimes her hip and leg would hurt prior to getting the vaccine'. There were no concomitant medications. Caller received the covid shot on Wednesday, 20Jan2021, her arm was sore yesterday (21Jan2021) but better today (22Jan2021). Caller reports worsening hip and leg pain on 22Jan2021 because sometimes her hip and leg would hurt prior to getting the vaccine. Caller would like to know if it's okay to have taken Tylenol for her symptoms after taking the covid vaccine. Response: The interim ACIP guidelines note that, "Antipyretic or analgesic medications (e.g., acetaminophen, non-steroidal anti-inflammatory drugs) may be taken for the treatment of post-vaccination local or systemic symptoms, if medically appropriate. However, routine prophylactic administration of these medications for the purpose of preventing post-vaccination symptoms is not currently recommended, as information on the impact of such use on Pfizer-BioNTech COVID-19 vaccine-induced antibody responses is not available at this time.& quot; If you are a patient, you should discuss this with your healthcare provider. Caller would like to know how long the symptoms from the covid vaccine would last. Calling about the Pfizer COVID vaccine she took it on Wednesday (20Jan2021), the Pfizer Biontech, and yesterday (21Jan2021) her arm was sore all day, which is probably to be expected, but today (22Jan2021), she has, her hips and legs feel real achy, she has achiness in her hips and legs, it was asked if that is normal. it was asked if it is a side effect from the shot. Her arm is not like it was yesterday (21Jan2021) if the achiness was a side effect, she thought she may have had it yesterday (21Jan2021), but she didn't, just today (22Jan2021). The outcome her arm was sore yesterday but better today/her arm was sore was recovering. The outcome of other events was not recovered.

Other Meds:

Current Illness: Leg pain (prior to getting the vaccine); Pain in hip (prior to getting the vaccine)

ID: 1010621
Sex: F
Age:
State: NY

Vax Date: 01/19/2021
Onset Date: 01/20/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tingling around the mouth area and lips; her mouth or lips were moving in a way that she had no control over/It was just a feeling she was having; This is a spontaneous report from a contactable consumer (patient). A 91-year-old female patient received the first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE)Lot # EL3247, via an unspecified route of administration on 19Jan2021 18:00 at single dose at left shoulder for covid-19 immunisation. Medical history included osteoporosis from Aug2020, rash on her legs from Aug2020, (lower leg below the knee, she was using a steroid but she had stopped as she was told not to use it too often by her doctor and just use Vaseline to keep the skin moist. She was asked if she had used any steroids but she hadn't used it in the past week and maybe only once in the previous week but couldn't be certain it wasn't in the last 10 days. She resisted the urge to use Mometasone 0.01 as it damaged the skin.); allergies to Sulfa a few years before. The patient reported her daughter who died at 41 years old of breast cancer. There were no concomitant medications. There was no additional vaccines administered on same date of BNT162B2 and no prior vaccinations within 4 weeks.The patient previously took brimonidine tartrate/timolol maleate (COMBIGAN) a few years before and experienced allergies, the eye drops didn't her any good at all and was told not to use it anymore. She previously received flu shot most every year and never had a problem. She stated that evening on 19Jan2021 she felt fine and then the next morning on 20Jan2021 she experienced tingling around the mouth area and lips. Almost as though her mouth or lips were moving in a way that she had no control over. She looked in the mirror and saw no evidence of it moving but could feel it moving. It was just a feeling she was having. The feeling was about the same. The first 2 days was on just the right side but she has had now had 2 occasions where it was on the left side. This was not constant, just occasionally during the day. She wanted to know if this was a known side effect and will it go away. She wanted to know if she should receive the second dose of the vaccine considering these side effects.The outcome of the events was not resolved.

Other Meds:

Current Illness:

ID: 1010622
Sex: F
Age:
State: RI

Vax Date: 01/20/2021
Onset Date: 01/22/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pain and swelling in arm pit of left arm; pain and swelling in arm pit of left arm; This is a spontaneous report from a contactable Non-healthcare Professional. This Non-healthcare Professional reported that a 44-years-old female patient received bnt162b2 (BNT162B2; brand=Pfizer COVID; lot number=EL3302) second dose, via an unspecified route of administration at Left arm on 20Jan2021 11:30 AM at SINGLE DOSE for covid-19 immunisation. Medical history included lymphocytic colitis from an unknown date and unknown if ongoing, diagnosed with covid-19 prior to vaccination. No Allergies to medications, food, or other products. Historical vaccine included received first dose of Pfizer COVID 19 vaccine (lot number=EL3246) on 30Dec2020 at left arm for covid-19 immunization. Concomitant medication included budesonide and OTC vitamins. The patient experienced pain and swelling in arm pit of left arm on 22Jan2021 08:00 AM with outcome of recovering. No treatment received. The events reported as non-serious.The patient was not pregnant and not Pregnant at the time of vaccination.The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient not been tested for COVID-19.

Other Meds: BUDESONIDE

Current Illness:

ID: 1010623
Sex: F
Age:
State: FL

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: nervous; This is a spontaneous report from a contactable consumer via a Pfizer-sponsored program. This (age: 78 units: unspecified) female consumer (patient) reported that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 22Jan2021 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient stated that she got first dose of the Covid vaccine by Pfizer today (22Jan2021) and they gave her next appointment about 4 weeks later. She stated she was nervous (22Jan2021), so did not see that its 4 weeks apart instead of 3 weeks apart until she got home. She was scheduled to get the 2nd dose of the Covid vaccine 4 weeks from date of 1st dose instead of 3 weeks and patient was wondering if this was ok. Outcome of event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1010624
Sex: M
Age:
State: NC

Vax Date: 01/09/2021
Onset Date: 01/17/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Peripheral facial paralysis (Bell's Palsy) left side 8 days after vaccination; This is a spontaneous report from a contactable 49-year-old male other healthcare professional (HCP) (patient) reported for himself received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3246) via unspecified route on left arm single dose for COVID-19 immunization on 09Jan2021, 02:30 PM, at 49-year-old. Medical history included: Borderline Type 2 diabetes; Hepatitis B carrier. No allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included: metformin, entecavir. The patient did not receive any other vaccines within 4 weeks prior to the BNT162B2. The patient had peripheral facial paralysis (Bell's Palsy) left side 8 days after vaccination (17Jan2021) and was reported as non-serious. Treatment was received as steroids and antiviral. Emergency room/department or urgent care visited. Since the vaccination, the patient had not been tested for COVID-19. Action taken for BNT162B2 was not applicable. Outcome of the event was not resolved.; Sender's Comments: Based on currently known drug safety profile, a causal association between the reported event peripheral facial paralysis and BNT162B2 cannot be fully excluded. The event facial paralysis can also be caused by other virus infection. Case will be reassessed when additional information is available including viral testing. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and investigators, as appropriate.

Other Meds: METFORMIN; ENTECAVIR

Current Illness:

ID: 1010625
Sex: F
Age:
State: HI

Vax Date:
Onset Date:
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: general body aches; and general body aches, described as similar to flu symptoms; headache; This is a spontaneous report from a contactable consumer reporting for a patient. An adult female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced headache that lasted about a day and a half and general body aches, described as similar to flu symptoms. Outcome of the events was resolved. This case was reported as non-serious. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1010626
Sex: F
Age:
State: NC

Vax Date: 01/20/2021
Onset Date: 01/21/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Body aches; fever(100.1); chills; runny nose; cough; headache; fatigue; neck pain; head congestion; This is a spontaneous report from a contactable nurse reporting for herself. A 61-year-old female patient (non-pregnant) received 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL9261), via an unspecified route of administration on 20Jan2021 at single dose on left arm for COVID-19 immunisation. Medical history included Irritable Bowel Syndrome with Constipation (IBSC), anxiety, allergies, Known allergies: sulfa. Historical vaccine included 1st dose of BNT162B2 (lot: EL1284) on 28Dec2020 at 14:00 via intramuscular at single dose on right arm for COVID-19 Immunization. Concomitant medication included celecoxib (CELEXA [CELECOXIB]), montelukast sodium (SINGULAIR), cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), lisdexamfetamine mesilate (VYVANSE) and linaclotide (LINZESS). The patient experienced body aches, fever (100.1), chills, runny nose, cough, headache, fatigue, neck pain and head congestion, all on 21Jan2021 at 14:45 with outcome of resolving.No treatment was received for the events. This case was reported as non-serious.

Other Meds: CELEXA [CELECOXIB]; SINGULAIR; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; VYVANSE; LINZESS

Current Illness:

ID: 1010627
Sex: F
Age:
State: CT

Vax Date:
Onset Date:
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: severe arm soreness; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Pregnant at the time of vaccination was unknown. Did the patient receive any other vaccines within 4 weeks prior to the COVID vaccine was unknown. Patient experienced severe arm soreness after the first injection with outcome recovered on an unspecified date. It was unknown whether treatment was received or not. Event was considered non-serious. Prior to vaccination, was the patient diagnosed with COVID-19 was unknown. Since the vaccination, has the patient been tested for COVID-19 was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1010628
Sex: F
Age:
State:

Vax Date: 01/13/2021
Onset Date: 01/20/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: She tested positive on 20Jan and is currently asymptomatic; She tested positive on 20Jan and is currently asymptomatic; This is a spontaneous report from a contactable nurse (patient) from a Pfizer-sponsored program. The 84-years-old female patient received first dose of bnt162b2 (BNT162B2, lot number: EL1283), via an unspecified route of administration on 13Jan2021 at SINGLE DOSE as Preventive and healthcare worker. Medical history and concomitant medications were none. Caller received the first dose of the vaccine on 13Jan. She tested positive on 20Jan and is currently asymptomatic. Her next dose of the vaccine is due on 29Jan and wants to know if she should get this at a later date. The outcome of the events was not recovered. No follow-up attempts are possible, information on batch number cannot be obtained.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation. However, full immunity is only expected 2 weeks after the second dose.

Other Meds:

Current Illness:

ID: 1010629
Sex: F
Age:
State: MI

Vax Date: 01/20/2021
Onset Date: 01/22/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Arm pit area swollen/ inflamed lymph nodes; Arm pit area swollen/ inflamed lymph nodes; This is a spontaneous report from a contactable Health Professional reported for herself. A 36-year-old female patient received her second single dose of BNT162B2 (Pfizer-BioNTech Covid-19 vaccine, lot number Ek9231) at right arm 14:30 on 20Jan2021 for Covid-19 immunization. Patient received her first shot at right arm 02:30 PM on 30Dec2020. The patient was allergic to penicillin. Concomitant medication was none. The patient had not received any other vaccines within 4 weeks prior to the Covid-19 vaccine. On 22Jan2021, the patient experienced arm pit area swollen/ inflamed lymph nodes. No treatment was received. The events did not resolve at the time of reporting. The events were reported as non-serious. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.

Other Meds:

Current Illness:

ID: 1010630
Sex: F
Age:
State: CA

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: joint pain; chills; Fatigue; This is a spontaneous report from a contactable Other Health Professional reported for herself. A 50-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 21Jan2021 at 10:15 at single dose on left arm for COVID-19 immunisation. Medical history included high blood pressure, thyroid cancer, allergy to penicillin and prior to vaccination, was the patient diagnosed with COVID-19. Concomitant medication included irbesartan, fish oil, vitamin D3 (VITAMIN D3). The patient experienced joint pain, chills, fatigue, all on 22Jan2021 05:15 with outcome of not recovered. Since the vaccination, the patient had not been tested for COVID-19. This case was reported as non-serious. Information on the lot/batch number has been requested.

Other Meds: IRBESARTAN; FISH OIL; VITAMIN D3

Current Illness:

ID: 1010631
Sex: F
Age:
State: AZ

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Severe headache; This is a spontaneous report from a contactable consumer. A 60-year-old female patient received 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL3249), via an unspecified route of administration on 14Jan2021 05:15 at single dose on left arm for COVID-19 immunisation. Medical history included diabetes. Patient had no known allergies to medications, food, or other products. The patient's concomitant medications included metformin. The patient experienced severe headache on 14Jan2021 with outcome of unknown. No treatment was received for the event. Since the vaccination, the patient had been tested for COVID-19 on 14Jan2021 with unknown result. This case was reported as non-serious.

Other Meds: METFORMIN

Current Illness:

ID: 1010632
Sex: F
Age:
State: WA

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: injection site (arm) soreness; This is a spontaneous report from a contactable consumer. This consumer reported a 39-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via unspecified route on arm single dose for COVID-19 immunization on 20Jan2021 at 39-year-old. Medical history and concomitant medication were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had injection site (arm) soreness on 20Jan2021 and was reported as non-serious. No treatment received. Since the vaccination, the patient had not been tested for COVID-19. Action taken for BNT162B2 was not applicable. Outcome of the event was resolving. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1010633
Sex: F
Age:
State: CT

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Mildly sore 2 inches around the vaccination site; This is a spontaneous report from a contactable consumer reported for herself. A 52-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=EL 3247) on 22Jan2021 11:30 AM at single dose (vaccine location=right arm) for Covid-19 immunization. Medical history was none. Concomitant medications included vitamins (unspecified) and birth control. Patient was not pregnant at the time of vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced Mildly sore 2 inches around the vaccination site on 22Jan2021, no treatment received for the adverse event. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. The outcome of event was recovering.

Other Meds:

Current Illness:

ID: 1010634
Sex: F
Age:
State:

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: site was itching; Arm was hurting; Body is warm; excruciating Headache; Hypertension; This is a spontaneous report from a contactable consumer (patient). A 69-year-old female patient received her first dose of bnt162b2 (BNT162B2 also reported as Pfizer-BioNTech COVID-19 vaccine, lot/ batch number and expiry date were not reported), via an unspecified route of administration on 20Jan2021 at SINGLE DOSE for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On 20Jan2021, she had an excruciating headache and her body was warm. She had hypertension. On Thursday (21Jan2021) her arm was hurting. Today (23Jan2021) the site was itching. She did not take a temperature. The outcome of events was unknown. Information on the Batch/Lot number has been requested.

Other Meds:

Current Illness:

ID: 1010635
Sex: F
Age:
State: MO

Vax Date: 01/20/2021
Onset Date: 01/22/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Severe lower stomach cramps; diarrhea; some bloody stool; This is a spontaneous report from a contactable other healthcare professional reported for herself. A 64-years-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EL32495-21), via an unspecified route of administration at Left arm on 20Jan2021 14:15 at single dose for COVID-19 immunization. Medical history included allergies to penicillin, allergies to Latex and allergies to shellfish. Concomitant medication included rosuvastatin calcium (CRESTOR), raloxifene hydrochloride (EVISTA), tramadol, ibuprofen 600 mg received within 2 weeks of vaccination. The patient previously took iodine and experienced allergies to Iodine, codeine and experienced allergies to codeine, oxytetracycline (TERRAMYCIN) and experienced allergies to Terramycin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced severe lower stomach cramps and diarrhea since 22Jan2021 19:30 and still having this issue to include some bloody stool on 22Jan2021 12:30. No treatment received for the events. The events were reported as non-serious. The patient was not pregnant. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was not recovered.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.

Other Meds: CRESTOR; EVISTA; TRAMADOL; IBUPROFEN

Current Illness:

ID: 1010636
Sex: F
Age:
State: TN

Vax Date: 01/02/2021
Onset Date: 01/22/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: When she starts sneezing like this, she then stars coughing and her nose stops up; When she starts sneezing like this, she then stars coughing and her nose stops up; picked up an allergy; she began sneezing on the way to get the second dose the Covid 19 vaccine today and has not stopped since; This is a spontaneous report from a contactable consumer. This consumer reported for herself that a 84-years-old female patient received bnt162b2 (BNT162B2; PFIZER-BIONTECH COVID-19 VACCINE; Batch/lot number: EL3247) first dose, via an unspecified route of administration on 02Jan2021 at SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced she began sneezing on the way to get the second dose the covid 19 vaccine today and has not stopped since on 22Jan2021, when she starts sneezing like this, she then stars coughing and her nose stops up on an unspecified date, picked up an allergy on an unspecified date. Patient stated she began sneezing on the way to get the second dose the Covid 19 vaccine today and has not stopped since. She would like to know if she could take a Benadryl. When she started sneezing like this, she then started coughing and her nose stopped up. She was experiencing all these symptoms currently. The patient had a question: she had the second dose of Pfizer COVID vaccine, may she took a Benadryl, she didn't want anything to affect the vaccine working, someone suggested not taking things like aspirin, Aleve, Tylenol, 24 hours after the vaccine, as it may effect the potency. She sneezed before the shot, now she was not blaming the shot, she went out and walked this morning and may have picked up an allergy, but she sneezed all the way to the shot, and she has been sneezing all afternoon and her nose was stopped up, she wanted to know if can take Benadryl, she wanted to clarify this started before she had the shot. She hasn't had this in years this bad, she was stopped up this afternoon, and thought to take a Benadryl that can help this, but she didn't want to mess the shot up. The outcome of event sneezing was not recovered, outcome for other events was unknown.

Other Meds:

Current Illness:

ID: 1010637
Sex: F
Age:
State: IN

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Couldn't hold a cup to drink; Pharangitis; Couldn't get warm; Strange odor in her nose, like burning plastic; Taste started to diminish; Painful bilateral lower back pain; Cough/Dry cough; Bad headache; Severe shaking chills; Muscles and joints ached; Muscles and joints ached; This is a spontaneous report from a contactable nurse (patient). A 74-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK9231), via an unspecified route of administration at left deltoid on 20Jan2021 at 9:30-9:45 am at SINGLE DOSE for COVID-19 immunization. Medical history included exposure to radiation from 2017 to an unknown date and did lose some of her sense taste due to 2 massive doses of radiation in 2017). There were no concomitant medications. Historical vaccine included two doses of shingles vaccine (SHINGRIX) for Immunization and experienced shaking, chills, and muscle and joint pain after the vaccine. The patient experienced bad headache (disability) on 20Jan2021 17:00 with outcome of recovered on 21Jan2021, Severe shaking chills (disability) on 20Jan2021 17:00 with outcome of recovered on 21Jan2021, muscles and joints ached (disability) on 20Jan2021 17:00 with outcome of recovered on 21Jan2021, couldn't hold a cup to drink on an unspecified date with outcome of unknown, painful bilateral lower back pain on 20Jan2021 17:00 with outcome of recovered on 21Jan2021, cough/dry cough on 20Jan2021 17:00 with outcome of not recovered (reported as worsened), strange odor in her nose, like burning plastic on 21Jan2021 with outcome of not recovered, taste started to diminish on 21Jan2021 with outcome of not recovered, pharangitis on an unspecified date with outcome of unknown, couldn't get warm on an unspecified date with outcome of unknown. Details were as follows: the patient received the COVIED in the morning of 20Jan2021. By 5pm she had developed a headache, severe shaking, chills, muscle and joints pain, severe lower back pain, and a dry cough; she was miserable. A few years ago after her double dosing of the shingles vaccine she had a similar reaction of shaking, chills, and muscle and joint pain. She has no product details for that product, no NDC, Lot, or expiry to provide. The patient confirmed that the shingles shot was 2 doses, not a double dose given at one time. When asked a seriousness criteria it was explained that the symptoms that started on the 20th, she felt they were disabling. She couldn't get warm, stop shaking, couldn't hold a cup and the pain was severe and she has high tolerance for pain. By around 3pm that day on the 21Jan2021 everything but the dry cough had resolved, and that had gotten worse. She also developed new symptoms. She had strange odor in her nose, like burning plastic and her sense of taste started to diminish. She did lose some of her sense taste due to 2 massive doses of radiation in 2017, She has no product information, NDC, Lot or Expiry for that radiation but after that she did have taste, some of it did come back. On the 21Jan2021, it was less, the sense of taste and now today she has no taste at all. For the muscle and joint pain she took Aleve. She was told if she was feeling worse over the weekend to go to the ER or urgent care. The patient was wondering and thinking this was her normal response to the vaccine just like she had a normal response that shingles vaccine.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 1010639
Sex: F
Age:
State: MI

Vax Date: 01/15/2021
Onset Date: 01/01/2021
Rec V Date: 02/08/2021
Hospital: Y

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: accompanied with very severe chest pain; Pericarditis; woke up with a severe headache; severe pain; continues to have muscle pain; weakness; shortness of breath when she walks; This is a spontaneous report from a contactable consumer. A 75-year-old female patient received first dose of BNT162B2 (lot number and expiry date not provided), via an unspecified route of administration on 15Jan2021 10:30 at single dose for COVID-19 immunization. There were no medical history. The patient was not pregnant at the time of vaccination. The patient's concomitant medications were not reported. On 16Jan2021 04:00, she went to bed at night and woke up at 4 AM with a severe headache. She took Aleve and went back to bed. When she woke up at 8:30 AM her headache was very severe and was accompanied with very severe chest pain. She immediately took her to the ER. They did a very thorough work up to check on her heart and Aorta. They managed her severe pain with two doses of morphine followed by two days of Dilaudid. The imaging and symptoms left her with a newly discovered diagnosis of Pericarditis. The medical professions were sure this was a result of the COVID vaccine. They continued to treat her for a few days and sent her home with anti inflammatories to help. She continues to have muscle pain, weakness and shortness of breath when she walks. She is scheduled to take her 2nd dose on February 5th but we are very concerned and hesitant as we don't want to cause any more damage to her heart. The patient was hospitalized for events 'headache', 'chest pain;', 'pericarditis' and 'pain' for 4 days. The patient did not receive any other vaccines within four weeks prior to the vaccination and did not received any other medications within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. The patient underwent lab tests and procedures which included imaging: pericarditis on 16Jan2021 and Nasal Swab: negative on 16Jan2021. Therapeutic measures were taken as a result of all the events which included Colchicine and prednisone, morphine and dilaudid. The outcome of the events was recovering. The events "headache", "chest pain", "pericarditis"and "severe pain" were assessed as serious due to hospitalization and disability. The events "myalgia", "asthenia" and "dyspnea" were assessed as serious due to disability. The events ('headache', 'chest pain;', 'pericarditis' and 'pain') resulted in emergency room visit. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1010640
Sex: F
Age:
State:

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: The injection site looks bruised as if a blood vessel was nicked; There was quite a bit of blood; This is a spontaneous report from a contactable pharmacist (patient). A 22-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 21Jan2021 at single dose in the arm for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient got the 1st dose of the Pfizer-BioNTech COVID-19 Vaccine yesterday (21Jan2021). She noticed that when the Pharmacist pulled it out of arm, there was quite a bit of blood and upon checking today (22Jan2021), the injection site looks bruised as if a blood vessel was nicked. Events outcome was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1010641
Sex: F
Age:
State: WA

Vax Date: 01/19/2021
Onset Date: 01/20/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: marked swelling; swollen lymph nodes under left arm, armpit, neck and collarbone area all on left side; Very Painful; This is a spontaneous report from a contactable healthcare professional, the patient. A 48-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number: EL3302), via an unspecified route of administration on 19Jan2021 at 12:00 (at the age of 48-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included diabetes. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unspecified medications that were received within 2 weeks of vaccination. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number: EL1284), via an unspecified route of administration on 29Dec2020 at 12:00 (at the age of 48-years-old) as a single dose in the left arm for COVID-19 immunization. On 20Jan2021 at 06:00, the patient experienced marked swelling and swollen lymph nodes under left arm, armpit, neck and collarbone area all on left side, very painful. The patient stated she did not have redness. The clinical outcomes of the swelling, swollen lymph nodes under left arm, armpit, neck and collarbone area all on left side, and pain were not recovered. It was also reported that since the vaccination, the patient has been tested for COVID-19, the patient had PCR nasal swab on 18Jan2021, which was negative and rapid test nasal swab on 21Jan2021 which was negative.

Other Meds:

Current Illness:

ID: 1010642
Sex: F
Age:
State:

Vax Date: 01/19/2021
Onset Date: 01/01/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: injection site pain; chills; muscle aches; fatigue; Rash on torso, arms; This is a spontaneous report from a non-contactable other hcp (patient). A 60-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 19Jan2021 14:30 at single dose in Left arm for covid-19 immunisation. The patient was not Pregnant at the time of vaccination. Medical history was none. Concomitant drug received within 2 weeks of vaccination included Multivitamin. The patient previously received first dose of BNT162B2 on 29Dec2020 03:15 PM at single dose in Left arm for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. After 6 hrs on 19Jan2021 21:00 PM, the patient experienced injection site pain. After 12 hrs the patient experienced chills, muscle aches, fatigue in Jan2021. The patient experienced Rash on torso, arms 36 hours after in Jan2021. The outcome was Recovering. No treatment received for events. The events were assessed non-serious. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No follow-up attempts are possible, information about batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1010643
Sex: F
Age:
State: AL

Vax Date: 01/14/2021
Onset Date: 01/15/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever; chills; fatigue; nauseous; throwing up; Diarrhea; severe stomach pain; stomach pain with swelling and feeling bloated; no appetite; This is a spontaneous report from a contactable healthcare professional (HCP) reporting for herself. A 69-year-old female patient received first single dose of BNT162B2 (Solution for injection, lot number: EJ 1686, exp date not reported), via an unspecified route of administration (left arm) on 14Jan2021 13:45 for COVID-19 immunization. Facility where the most recent COVID-19 vaccine was administered: Nursing Home/Senior Living Facility. Medical history included allergies to seafood, latex, and steroids. The patient had COVID prior to vaccination (date/s unknown). The patient had no other relevant history. The patient was not pregnant at time of vaccination and was not pregnant at the time of reporting. Concomitant medications/other medications the patient received within 2 weeks of vaccination included amoxicillin, calcium, cinnamomum verum (CINNAMON), chromium, and multivitamin (unspecified). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took ephedrine and codeine and experienced allergy to both. On 15Jan2021 13:30, the patient experienced fever, chills, fatigue, nauseous, throwing up, diarrhea, severe stomach pain with swelling and feeling bloated; and no appetite. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The events were considered as non-serious by the reporter. Treatment for the events included ondansetron (ZOFRAN), dexamethasone 0.5 (unit not reported), and doxycycline 20 mg. Since the vaccination, the patient has not been tested for COVID-19. The patient was recovering from the events at the time of reporting.

Other Meds: AMOXICILLIN; CALCIUM; CINNAMON; CHROMIUM

Current Illness:

ID: 1010644
Sex: M
Age:
State: GA

Vax Date: 01/12/2021
Onset Date: 01/13/2021
Rec V Date: 02/08/2021
Hospital: Y

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Trouble breathing; Lightheaded/dizzy; Chills; Sore all over; Weakness in legs; Chest pain; This is a spontaneous report from a contactable consumer (patient). This 21-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EK9231), via an unknown route, on 12Jan2021 at a single dose on the left arm for COVID-19 immunisation. No relevant medical history and concomitant medications were provided. No known allergies. Pre-vaccination COVID test was not performed. On 13Jan2021, at 05:00 PM, the patient had lightheaded/dizzy, chills, sore all over, weakness in legs, chest pain and trouble breathing. On 14Jan2021, COVID test (Nasal Swab) was done and resulted negative. The events required an emergency room visit. Then, the patient was hospitalized for 3 days due to the events. Therapeutic measures taken as result of the events included ibuprofen and 2 other medications. The patient was recovering from the events.

Other Meds:

Current Illness:

ID: 1010645
Sex: F
Age:
State: PA

Vax Date: 01/14/2021
Onset Date: 01/17/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: contracted Covid after my 2nd dose, 3 days to be exact; contracted Covid after my 2nd dose, 3 days to be exact; This is a spontaneous report from a contactable other health professional (patient). A 66-year-old female patient received the 2nd dose of bnt162b2 (BNT162B2, Lot # EL3246) at single dose at right arm on 14Jan2021 for covid-19 immunisation, administered at hospital. Medical history included rheumatoid arthritis, allergies to morphine and related, PCN, sulfa, quinidine, Xeljanz. Patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication within 2 weeks of vaccination included: upadacitinib (RINVOQ), folic acid (FOLIC ACID), ropinirole hydrochloride (REQUIP). The patient previously received the 1st dose of bnt162b2 (BNT162B2, Lot # EJ1685) at single dose at right arm on 26Dec2020 03:00 PM for covid-19 immunisation, administered at hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced contracted Covid after her 2nd dose, muscle aches and fatigue 3 days to be exact on 17Jan2021 17:00, Covid test result positive on 22Jan2021. Since the vaccination, the patient has been tested for COVID-19 (nasal swab): positive on 22Jan2021. No treatment was received for the adverse event. The outcome of Covid test result positive was unknown, of the other events was recovering.; Sender's Comments: A possible contributory effect of suspect BNT162B2 on reported lack of efficacy cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds: RINVOQ; FOLIC ACID; REQUIP

Current Illness:

ID: 1010646
Sex: U
Age:
State: VA

Vax Date: 01/13/2021
Onset Date: 01/21/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: testing positive for COVID after receiving vaccine; testing positive for COVID after receiving vaccine; This is a spontaneous report from a contactable pharmacist. This pharmacist reported similar event for 14 patients. This is 1st of 14 reports. An elderly patient (more than 65 years old) of an unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 13Jan2021 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced testing positive for COVID after receiving vaccine on 21Jan2021 with outcome of unknown. It was reported that 8 patients and 6 workers at a long term care facility were vaccinated on 13Jan2021 and reported testing positive for COVID on 21Jan2021. Since they were testing positive, physician wanted to administer bamlanirimab (drug being administered under FDA EUA). The event resulted in doctor or other healthcare professional office/clinic visit. Outcome of the events was unknown. Information about lot/batch number has been requested.; Sender's Comments: Based on the information currently available, a lack of efficacy with the suspected vaccine BNT162B2 in this patient cannot be completely excluded. Further information like confirmative virus genome /nucleic acid detection is needed for meaningful medical assessment.,Linked Report(s) : US-PFIZER INC-2021065206 same reporter/drug/event, different patient.;US-PFIZER INC-2021065202 same reporter/drug/event, different patient.;US-PFIZER INC-2021065199 same reporter/drug/event, different patient.;US-PFIZER INC-2021065208 same reporter/drug/event, different patient.;US-PFIZER INC-2021065203 same reporter/drug/event, different patient.;US-PFIZER INC-2021065200 same reporter/drug/event, different patient.;US-PFIZER INC-2021065205 same reporter/drug/event, different patient.;US-PFIZER INC-2021065210 same reporter/drug/event, different patient.;US-PFIZER INC-2021065201 same reporter/drug/event, different patient.;US-PFIZER INC-2021065209 same reporter/drug/event, different patient.;US-PFIZER INC-2021065207 same reporter/drug/event, different patient.;US-PFIZER INC-2021065198 same reporter/drug/event, different patient.;US-PFIZER INC-2021065204 same reporter/drug/event, different patient.

Other Meds:

Current Illness:

ID: 1010647
Sex: F
Age:
State: TX

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tired; Feel bad; Weak; Sore arm; Fever 100.3; This is a spontaneous report from a contactable consumer reported for herself. A 45-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; brand: Pfizer; lot number: unknown; reason why batch/lot was unknown: misplaced/discarded) via an unspecified route of administration at left arm on 21Jan2021 09:45 AM at a single dose for COVID-19 immunization. Medical history included anxiety, high blood pressure (HBP). Since Covid - short of breath still racing heart. Allergies to medications, food, or other products included penicillin and apple juice. Prior to vaccination, the patient was diagnosed with COVID-19 (short of breath still racing heart). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Other medications the patient received within 2 weeks of vaccination included niacin, lisinopril, venlafaxine and montluskat for allergy. Facility where the most recent COVID-19 vaccine was administered was at public health clinic/veterans administration facility. The patient was not pregnant at the time of vaccination. The patient experienced adverse events included tired, feel bad/weak, sore arm, fever 100.3; with start date on 22Jan2021 at 03:00 PM. The events were reported as non-serious. The outcome of events was resolving. Treatment Tylenol received for fever. Since the vaccination, the patient had not been tested for COVID-19. Information on the lot/batch number has been requested.

Other Meds: NIACIN; LISINOPRIL; VENLAFAXINE; MONTELUKAST

Current Illness:

ID: 1010648
Sex: F
Age:
State: NY

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sleeplessness; Diarrhea; Nausea; Headache; Fatigue; This is a spontaneous report from a non-contactable consumer (patient): A 39-year-old female patient received the 1st doe of bnt162b2 (BNT162B2, batch/lot is unknown misplaced/discarded) at single dose at right arm on 21Jan2021 19:00 for covid-19 immunisation, administered at hospital Medical history included ankylosing spondylitis, uveitis, coeliac disease, postural orthostatic tachycardia syndrome (POTS), food allergy, mycotic allergy. Allergies: Coconut, ASPIRIN, REGLAN, mold. Patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication within 2 weeks of vaccination included: atenolol (manufacturer unknown), cetirizine hydrochloride (ZYRTEC), infliximab (REMICADE). The patient received no other vaccines within 4 weeks prior to the COVID vaccine. On 22Jan2021 12:00 AM the patient experienced sleeplessness, diarrhea, nausea, headache and fatigue. No treatment received for the adverse events. Events were considered non serious. Since the vaccination, the patient has not been tested for COVID-19. The outcome of events was recovering. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: ATENOLOL; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; REMICADE

Current Illness:

ID: 1010649
Sex: F
Age:
State: CA

Vax Date: 01/20/2021
Onset Date: 01/22/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: swelling; hot to touch; started lightly at injection site but rash more prominent on sides and back of neck; started lightly at injection site but rash more prominent on sides and back of neck; scratch throat; This is a spontaneous report from a contactable other health professional (patient). A 34-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number and expiration date unknown due to not available/provided to reporter at the time of report completion), via an unspecified route of administration in left arm on 20Jan2021 13:30 at single dose for COVID-19 immunization. The patient's medical history included mild hashimotos (no meds, just monitor) and Polycystic ovarian syndrome (PCOS). No allergies to medications, food, or other products. The patient was not pregnant at the time of vaccination. Concomitant medications were not reported. It was reported that "48 hours" post injection patient developed neck rash, swelling, hot to touch, started lightly at injection site but rash more prominent on sides and back of neck, and scratch throat. All the events resulted in: emergency room/department or urgent care visit. Therapeutic measures were taken as a result of all the events: Steroid and Benadryl injection. The outcome of the events was recovered with lasting effects. The events was considered as non-serious by reporter, as no resulting in death, no life threatening, no causing/prolonging hospitalization, no disabling/Incapacitating, no congenital anomaly/birth defect. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Information on the lot/batch number has been requested.?; Sender's Comments: Causality cannot be excluded for PFIZER-BIONTECH COVID-19 VACCINE and the reported events.

Other Meds:

Current Illness:

ID: 1010650
Sex: M
Age:
State: MI

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: After injection, left side finger tips and face tingled. Finger tips resolved, face felt numb afterwards including head and neck. Feels like patient had dental work and the numbing is wearing off.; After face felt numb afterwards including head and neck. Feels like patient had dental work and the numbing is wearing off.; This is a spontaneous report from a contactable consumer reporting for himself. A 47-years-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot number EL3249, via an unspecified route of administration on 22Jan2021 10:00 (at the age of 47-years-old) as a single dose in the left arm for COVID-19 vaccination. Medical history included acromegaly (surgery done to remove tumor) from an unknown date and unknown. The patient's concomitant medications were not reported. The patient previously took doxycycline and experienced drug allergy. The facility where the most recent COVID-19 vaccine was administered was at a hospital.On 22Jan2021 10:00AM, the patient experienced after injection, left side finger tips and face tingled. Finger tips re-solved, face felt numb afterwards including head and neck. Feels like patient had dental work and the numbing is wearing off. The events after injection, left side finger tips and face tingled. Finger tips re-solved, face felt numb afterwards including head and neck. Feels like patient had dental work and the numbing is wearing off were reported as non-serious and did not result in death, was not life-threatening, did not cause/prolonged hospitalization, was not disabling/incapacitating and did not cause congenital anomaly/birth defect. No treatment was received for the events. The clinical outcomes of the "after injection, left side finger tips and face tingled. Finger tips resolved, face felt numb afterwards including head and neck. Feels like patient had dental work and the numbing is wearing off" was not recovered. Prior to the vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19.

Other Meds:

Current Illness:

ID: 1010651
Sex: M
Age:
State:

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tested Covid19 positive; tested Covid19 positive; This is a spontaneous report from a contactable pharmacist (patient). A 38-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 05Jan2021 or 06Jan2021 at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient received the first dose of vaccine on 05Jan2021 or 06Jan2021 and then 2 weeks later tested positive for COVID in Jan2021. The patient asked how long he was supposed to wait for the second dose. It was just a mild case and he has already recovered the few days in Jan2021. Information on the Lot/Batch number has been requested.; Sender's Comments: Based on available information, a possible contributory role of BNT162B2 cannot be excluded for "tested Covid19 positive".

Other Meds:

Current Illness:

ID: 1010652
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: she had the virus last year; she had the virus last year; This is a spontaneous report from a non-contactable consumer, the patient, via the Pfizer-sponsored program. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unspecified date (at an unspecified age) as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date in 2020 (reported as last year), the patient "had the virus". It was not confirmed if the patient received the 1st dose of the vaccination prior to or after having the virus. The patient queried if she should continue to receive the 2nd dose. The clinical outcome of "had the virus" was unknown. No follow-up attempts are possible; Information about batch/lot number cannot be obtained.

Other Meds:

Current Illness:

ID: 1010653
Sex: F
Age:
State: AZ

Vax Date: 01/23/2021
Onset Date: 01/23/2021
Rec V Date: 02/08/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sore arm at vaccination site; This is a spontaneous report from a contactable consumer (patient). A 53-year-old female patient received bnt162b2 (BNT162B2), lot number: EL1283, via an unspecified route of administration Left arm from 23Jan2021 14:15 to 23Jan2021 14:15 at SINGLE DOSE (first dose) for COVID-19 immunisation. Medical history included asthma and penicillin allergy. Concomitant medication included montelukast sodium 10 mg tab, fluticasone propionate, salmeterol xinafoate (ADVAIR), albuterol [SALBUTAMOL]. The patient experienced sore arm at vaccination site on 23Jan2021 15:00 with outcome of recovering. The patient is not pregnant at the time of vaccination. No treatment was received for the event.

Other Meds: MONTELUKAST SODIUM; ADVAIR; ALBUTEROL [SALBUTAMOL]

Current Illness:

Total 2021 VAERS Injuries: 704,237

Page last modified: 03 October 2021 5:28pm